SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-063730
Filing Date
2023-11-14
Accepted
2023-11-14 16:17:19
Documents
106
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q atai-20230930.htm   iXBRL 10-Q 5349500
2 EX-10.2 atai-ex10_2.htm EX-10.2 95875
3 EX-31.1 atai-ex31_1.htm EX-31.1 16304
4 EX-31.2 atai-ex31_2.htm EX-31.2 17954
5 EX-32.1 atai-ex32_1.htm EX-32.1 10145
6 EX-32.2 atai-ex32_2.htm EX-32.2 10052
7 GRAPHIC img105944471_0.jpg GRAPHIC 130893
  Complete submission text file 0000950170-23-063730.txt   23483876

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT atai-20230930_cal.xml EX-101.CAL 81869
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT atai-20230930_def.xml EX-101.DEF 745130
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT atai-20230930.xsd EX-101.SCH 162910
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT atai-20230930_pre.xml EX-101.PRE 966304
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT atai-20230930_lab.xml EX-101.LAB 1088927
100 EXTRACTED XBRL INSTANCE DOCUMENT atai-20230930_htm.xml XML 5401096
Mailing Address 524 BROADWAY NEW YORK NY 10013
Business Address WALLSTRASSE 16 BERLIN 2M 10179 (617)-699-5876
ATAI Life Sciences N.V. (Filer) CIK: 0001840904 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40493 | Film No.: 231406570
SIC: 2834 Pharmaceutical Preparations